Micrograph News and Research

RSS
Pfizer/BioNTech COVID-19 vaccine candidate BNT162b2 profiled for large scale clinical trials

Pfizer/BioNTech COVID-19 vaccine candidate BNT162b2 profiled for large scale clinical trials

New approach to chronic pain treatment could bring relief

New approach to chronic pain treatment could bring relief

Large SARS-CoV-2 outbreak on a fishing boat - neutralizing antibodies prevent infection

Large SARS-CoV-2 outbreak on a fishing boat - neutralizing antibodies prevent infection

Multiplication of ecDNA genes present in many cancer types, drives poor patients outcomes

Multiplication of ecDNA genes present in many cancer types, drives poor patients outcomes

Pre-COVID-19 coronavirus immunity does not protect against SARS-CoV-2

Pre-COVID-19 coronavirus immunity does not protect against SARS-CoV-2

Can the coronavirus SARS-CoV-2 be spread through frozen food?

Can the coronavirus SARS-CoV-2 be spread through frozen food?

Influenza-virus-based vaccine platform another viable option against SARS-CoV-2

Influenza-virus-based vaccine platform another viable option against SARS-CoV-2

SARS-CoV-2 a "swarm" of mutant viruses

SARS-CoV-2 a "swarm" of mutant viruses

Can SARS-CoV-2 be transmitted via feces?

Can SARS-CoV-2 be transmitted via feces?

Inhaled delivery of a potent neutralizing nanobody effective against SARS-CoV-2

Inhaled delivery of a potent neutralizing nanobody effective against SARS-CoV-2

Vaccine 'nationalism' will slow coronavirus fight if poor countries are left exposed

Vaccine 'nationalism' will slow coronavirus fight if poor countries are left exposed

Speed of Novavax vaccine development does not compromise quality of the SARS-CoV-2 immunogen

Speed of Novavax vaccine development does not compromise quality of the SARS-CoV-2 immunogen

Heat suggested as a therapeutic intervention in COVID-19

Heat suggested as a therapeutic intervention in COVID-19

Mice study shows a promising therapy for spinal cord injuries

Mice study shows a promising therapy for spinal cord injuries

Regeneron's COVID-19 antibody-drug cocktail treats SARS-CoV-2 virus in animals

Regeneron's COVID-19 antibody-drug cocktail treats SARS-CoV-2 virus in animals

NIH trial to evaluate potential new therapeutics for mild, moderate COVID-19

NIH trial to evaluate potential new therapeutics for mild, moderate COVID-19

Clinical trial to test safety, efficacy of antibody treatment in hospitalized COVID-19 patients

Clinical trial to test safety, efficacy of antibody treatment in hospitalized COVID-19 patients

SARS-CoV-2 spike protein recognized by innate immune receptors in a glycan-dependent way

SARS-CoV-2 spike protein recognized by innate immune receptors in a glycan-dependent way

Severe fatigue common in COVID-19, independent of disease severity

Severe fatigue common in COVID-19, independent of disease severity

New bivalent vaccine delivers robust cell-mediated and humoral immunity against SARS-CoV-2

New bivalent vaccine delivers robust cell-mediated and humoral immunity against SARS-CoV-2